These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37916324)

  • 1. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
    Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity.
    Yang R; Lai C; Huang L; Li F; Peng W; Wu M; Xin J; Lu Y; Ouyang M; Bai Y; Lei H; He S; Lin Y
    Front Immunol; 2024; 15():1409149. PubMed ID: 39399504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma.
    Liu J; Li H; Zhang N; Dong Q; Liang Z
    Curr Med Chem; 2024; 31(25):4034-4055. PubMed ID: 38685772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma.
    Huang J; Zhang J; Zhang F; Lu S; Guo S; Shi R; Zhai Y; Gao Y; Tao X; Jin Z; You L; Wu J
    Comput Biol Med; 2023 Oct; 165():107402. PubMed ID: 37657358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfidptosis-related gene
    Zhu J; Ge H; Chen Y; Zhang S; Wu J; Nai W; Min L
    Transl Cancer Res; 2024 Sep; 13(9):5064-5072. PubMed ID: 39430814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma.
    Qi C; Ma J; Sun J; Wu X; Ding J
    Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and assessing a prognostic model based on disulfidptosis-related genes: implications for immune microenvironment and tumor biology in lung adenocarcinoma.
    Wang J; Liu K; Li J; Zhang H; Gong X; Song X; Wei M; Hu Y; Li J
    Front Immunol; 2024; 15():1371831. PubMed ID: 38840910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
    Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
    Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disulfidptosis-related glucose metabolism and immune response prognostic model revealing the immune microenvironment in lung adenocarcinoma.
    Zhang K; Li G; Wang Q; Liu X; Chen H; Li F; Li S; Song X; Li Y
    Front Immunol; 2024; 15():1398802. PubMed ID: 39091494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
    Pan Y; Jin X; Xu H; Hong J; Li F; Luo T; Zeng J
    Sci Rep; 2024 Jun; 14(1):13113. PubMed ID: 38849442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma.
    Song Z; Cao X; Wang X; Li Y; Zhang W; Wang Y; Chen L
    Sci Rep; 2024 Feb; 14(1):4621. PubMed ID: 38409243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
    Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z
    Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
    Wang X; Yang J; Yang F; Mu K
    Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation.
    Wang Y; Xu Y; Liu C; Yuan C; Zhang Y
    Front Immunol; 2023; 14():1233260. PubMed ID: 37799714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study.
    Chen R; Jiang L
    Medicine (Baltimore); 2024 May; 103(22):e38398. PubMed ID: 39259065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
    Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
    Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
    Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
    Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
    Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
    Qu J; Guan H; Zheng Q; Sun F
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.